Delivery Order SPE2DB25D3022-SPE2DB25FWBZH
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,679.80 firm fixed-price delivery order is for TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,572.70 Firm Fixed Price delivery order is for TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,355.98 Firm Fixed Price Delivery Order is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $3,736.05, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The delivery order has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,177.63 firm fixed-price delivery order is for the medical supply TRELEGY ELLIPTA 100-62.5-25 60S. The contract has an ultimate completion date of May 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award, valued at $8,991.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication, with a completion date of January 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,613.38 Firm Fixed Price Delivery Order contract is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,589.76 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The contract has an ultimate completion date of May 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,351.89 delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The contract has a completion date of November 27, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,692.49 firm fixed-price delivery order is for the drug TRELEGY ELLIPTA 100-62.5-25 60S, which is used for various medical conditions. The contract has an ultimate completion date of July 22, 2024 and was awarded on July 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWBZHDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,017.78 by the Defense Logistics Agency on July 18, 2025, with an ultimate completion date of July 21, 2025. The delivery order, issued under a firm fixed-price contract type with no set-aside designation, covers the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used in treating chronic obstructive pulmonary disease. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a critical vendor in the Defense Health Agency's pharmaceutical supply chain, AmerisourceBergen Drug Corp fulfills a comprehensive range of medical procurement needs for military and veteran healthcare systems through competitively awarded contracts. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order represents one of numerous transactions executed under this expansive contract vehicle, demonstrating the company's ongoing capability to meet federal medical supply requirements efficiently and reliably.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 7/18/25 |